Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
- Published
Meanwhile On the Other Side of The Pond: Why a biopharmaceutical invention that was "obvious to try", still might not be obvious - Part I
Minssen, Timo, 2010, In: Chicago Kent Journal of Intellectual Property Law. 9, p. 60-131 71 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
Medicines authority regulators and industry perspectives on the European regulation of biosimilars
Druedahl, Louise C., De Bruin, M. L. (., van de Weert, Marco, Minssen, Timo, Hoogland, H. & Almarsdóttir, Anna Birna, 2019.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
- Published
Might the EPO’s Enlarged Board of Appeal step into the CRISPR patent battle and reconsider the “all applicants” approach?
Wested, Jakob, Minssen, Timo & Van Zimmeren, E., Jul 2018, Harvard Law School's Bill of Health blog.Research output: Other contribution › Net publication - Internet publication › Communication
- Published
More competition law-FRANDly IPR policies: A solution to SSOs’ problems of self-governance?
Kokoulina, Olga & Minssen, Timo, 29 Jul 2016, User Generated Law: Re-constructing Intellectual Property Law in the Knowledge Society. Riis, T. (ed.). Northampton, MA: Edward Elgar Publishing, p. 148-179 32 p.Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
- Published
More competition-law-FRANDly IPR policies: A solution to SSOs' problems of self-governance?
Kokoulina, Olga & Minssen, Timo, 29 Jul 2016, User Generated Law: Re-Constructing Intellectual Property Law in a Knowledge Society. Edward Elgar Publishing, p. 148-179 32 p.Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
- Published
Myriad reloaded and ready for the next round?
Minssen, Timo & Schwartz, R., Jan 2013, In: Queen Mary Journal of Intellectual Property. Vol 3, 1, p. 70-80 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Submitted
Navigating the EU AI Act: Implications for Regulated Digital Medical Products (under review)
Aboy, M., Minssen, Timo & Vayena, E., 2024, (Submitted) In: Nature PJ Digital Medicine.Research output: Contribution to journal › Journal article › Research › peer-review
- Accepted/In press
New drug-development paradigms? Opportunities and uncertainties with new government drug repurposing programmes
Liddicoat, J., Hamidzadeh , A., Liddell, K., Schito, M., Simon, D., Aboy, M. & Minssen, Timo, 2024, (Accepted/In press) In: Science Translational Medicine.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
New regulatory pathways and incentives for sustainable antibiotics: Recent European & US Initiatives
Minssen, Timo, Mar 2014Research output: Other contribution › Net publication - Internet publication › Research
- Published
Non-Fungible Tokens as a Framework for Sustainable Innovation in Pharmaceutical R&D: A Smart Contract-Based Platform for Data Sharing and Rightsholders Protection
Corrales Compagnucci, Marcelo, Nilsson, N., Wagner, P., Olsson, C., Fenwick, M., Minssen, Timo & Szkalej, K., 2023, In: International Review of Law, Computers & Technology. 38, 1, p. 66-85 20 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 16150437
Most downloads
-
4329
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2192
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2078
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published